1. Home
  2. Labeler Index
  3. Trigen Laboratories, Llc
  4. 13811-093
  5. Product Images: Estradiol

Product Images Estradiol

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 15 images provide visual information about the product associated with Estradiol NDC 13811-093 by Trigen Laboratories, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Table 1 - estradiol gel 1

Table 1 - estradiol gel 1

This is a table displaying the number and percentage of subjects experiencing common adverse reactions during a 12-week study of Estradiol Gel. The table lists the preferred terms for each system organ class, including infections and infestations and reproductive system and breast disorders. The table shows the number of subjects and percentage for each dose category of Estradiol Gel and a placebo group. The adverse reactions reported are those that were experienced by more than 5% of patients in any treatment group.*

Figure C - estradiol gel 10

Figure C - estradiol gel 10

Estradiol Gel 0.25 mg Carton - estradiol gel 11

Estradiol Gel 0.25 mg Carton - estradiol gel 11

Estradiol Gel 0.5 mg Carton - estradiol gel 12

Estradiol Gel 0.5 mg Carton - estradiol gel 12

Estradiol Gel 0.75 mg Carton - estradiol gel 13

Estradiol Gel 0.75 mg Carton - estradiol gel 13

Estradiol Gel 1 mg Carton - estradiol gel 14

Estradiol Gel 1 mg Carton - estradiol gel 14

Estradiol Gel 1.25 mg Carton - estradiol gel 15

Estradiol Gel 1.25 mg Carton - estradiol gel 15

Estradiol Gel Structural Formula - estradiol gel 2

Estradiol Gel Structural Formula - estradiol gel 2

Table 2 - estradiol gel 3

Table 2 - estradiol gel 3

The table presents average pharmacokinetic parameters for Estradiol on Day 14 after applying multiple daily doses of Estradiol Gel with different concentrations. The parameters include AUCo24, Crmax, Cavg, tmax, and E2:E1 ratio, and are expressed in different units. The values in parentheses indicate the coefficient of variation (%CV). The results suggest that increasing the concentration of Estradiol Gel leads to higher values for these parameters. The median, minimum, and maximum values are also provided.*

Figure 1 - estradiol gel 4

Figure 1 - estradiol gel 4

Table 3 - estradiol gel 5

Table 3 - estradiol gel 5

The table shows the median daily frequency and severity of hot flushes during estradiol gel treatment. The table compares the frequency and severity of hot flushes between different dosages of the gel and placebo over a period of 12 weeks. Median changes are calculated and compared using p-values. Significant differences are shown where p<0.05 based on van Elteren's test stratified by pooled center.*

Table 4 - estradiol gel 6

Table 4 - estradiol gel 6

This appears to be a table showing relative and absolute risk seen in a study called Esiroger-Alone Substudy of WHI, with various health outcomes such as heart disease, stroke, deep vein thrombosis, pulmonary embolism, breast cancer, and death. The study includes a comparison with a placebo group, and the results appear to be presented as rates per 1000 women-years with confidence intervals. There is no information on the methodology or population used in the study.*

Table 5 - estradiol gel 7

Table 5 - estradiol gel 7

Figure A - estradiol gel 8

Figure A - estradiol gel 8

Figure B - estradiol gel 9

Figure B - estradiol gel 9

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.